108 related articles for article (PubMed ID: 10628403)
1. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of 53 antibodies against prostate-specific antigen.
Bellanger L; Andrès C; Seguin P
Tumour Biol; 1999; 20 Suppl 1():18-23. PubMed ID: 10628404
[TBL] [Abstract][Full Text] [Related]
3. Immunological grouping of 53 antibodies against prostate-specific antigen.
Slota J; Lauren L; Rapp J; Dowell B
Tumour Biol; 1999; 20 Suppl 1():70-4. PubMed ID: 10628411
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
Paus E; Nustad K; Børmer OP
Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
[TBL] [Abstract][Full Text] [Related]
6. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
Jette DC; Kreutz FT; Suresh MR
Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen.
Leinonen J; Zhang WM; Paus E; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():28-34. PubMed ID: 10628406
[TBL] [Abstract][Full Text] [Related]
8. Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigen.
Zhou Z; Barnett TR; Very DL; Ng PC; Pellegrino CM; Davis G; Belenky A; Allard WJ; Yeung KK
Tumour Biol; 1999; 20 Suppl 1():86-93. PubMed ID: 10628414
[TBL] [Abstract][Full Text] [Related]
9. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
11. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen.
Stenman UH; Paus E; Allard WJ; Andersson I; Andrès C; Barnett TR; Becker C; Belenky A; Bellanger L; Pellegrino CM; Børmer OP; Davis G; Dowell B; Grauer LS; Jette DC; Karlsson B; Kreutz FT; van der Kwast TM; Lauren L; Leinimaa M; Leinonen J; Lilja H; Linton HJ; Nap M; Hilgers J
Tumour Biol; 1999; 20 Suppl 1():1-12. PubMed ID: 10628402
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
Chen Z; Chen H; Stamey TA
J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.
Lilja H; Christensson A; Dahlén U; Matikainen MT; Nilsson O; Pettersson K; Lövgren T
Clin Chem; 1991 Sep; 37(9):1618-25. PubMed ID: 1716536
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
15. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
17. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
19. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
[TBL] [Abstract][Full Text] [Related]
20. Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.
Zhou Z; Armstrong EG; Belenky A; Freeman JV; Yeung KK
J Clin Lab Anal; 1998; 12(4):242-9. PubMed ID: 9671177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
